Source: Pharmabiz

Bugworks: Bugworks Research and Cytecare Cancer Hospitals ink pact to propel development of immunooncology therapies

Bugworks, a US, India and Australia based start─up with globally recognized expertise in drug discovery, has set up a dedicated immuno─oncology ex vivo research lab at the Bengaluru─based hospital, Cytecare.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Anand Anandkumar's photo - Managing Director & CEO of Bugworks

Managing Director & CEO

Anand Anandkumar

CEO Approval Rating

87/100

Read more